Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Stage IIIb and IV Non Small Cell Lung Cancer 1Solid Tumor, Adult 1Rare Diseases 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplastic Syndromes, Hereditary 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Microsatellite Instability 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Medullary 1COVID-19 1Biliary Tract Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × High-Throughput Nucleotide Sequencing × Clear all
NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated
66 enrolled
CNS

Neoplasms, Neuroblastoma

NCT04261972 2026-01-14

CHARM1

University Health Network, Toronto

Active not recruiting
1,416 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Recruiting
3,500 enrolled

Neoplasms, Recurrence

NCT04345315 2020-04-15

CORSA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Unknown
500 enrolled

COVID-19, Neoplasms

NCT01458704 2011-10-25

Cancer Genome Analysis

Seoul National University Hospital

Unknown
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡